Coxiella Burnetii (Q-Fever) Phase 2 IgG

Coxiella Burnetii (Q-Fever) Phase 2 IgG
Artikelnummer
AVIGWB-2EB8D1-96W
Verpackungseinheit
96 Wells
Hersteller
Aviva Systems Biology

Verfügbarkeit: wird geladen...
Preis wird geladen...
Description of Target: _x000D__x000D__x000D__x000D__x000D__x000D__x000D__x000D__x000D__x000D__x000D__x000D__x000D__x000D__x000D__x000D__x000D__x000D__x000D__x000D__x000D__x000D__x000D__x000D_
Product NameMycoplasma pneumoniae IgM - ELISA
# of Samples1 x 96 Assays.
Intended UseThe Mycoplasma pneumoniae IgM - ELISA is intended for the qualitative determination of IgM class antibodies against M. pneumoniae in human serum or plasma (citrate).
IntroductionThe mycoplasms belong to the class Mollicutes comprising three distinct families and four genera, one of which is Mycoplasma with over 60 species. Mycoplasmae are the smallest freeliving organisms known (300 to 500 nm in diameter) and unlike regular bacteria they lack a cell wall. Mycoplasms are extracellular parasites, especially on mucous membranes, which can cause infections in hu-mans, animals, plants, and cell cultures. Mycoplasma pneumoniae is primarily a respiratory pathogen (obligat) in humans involving the nasopharynx, throat, trachea, bronchi, bronchioles, and alveoli. Other Mycoplasmae, M. buccale, M. faucium, M. orale and M. salivarium are commensals in the oral cavity. Mycoplasma hominis and Ureaplasma urealyticum inhabit primarily the genital tract and may act as opportunistic invaders. M. pneumoniae is by far the most important pathogen of this group. Infection with M. pneumoniae occurs worldwide, its epidemiology has been studied primarily in the USA, Europe, and Japan. Infections are endemic in larger urban areas, and epidemic increases are observed at varying intervalls. Mycoplasma pneumoniae has been estimated to cause 15-20% of all pneumoniae; the rate is highest in children and young adults. 74% of infections with M. pneumoniae are asymptomatic, reinfection may occur. Naturally acquired immunity to infection with M. pneumoniae appears to be of limited duration (2-3 years).
Infection may be identified by Microscopy Hemadsorption, Tetrazolium reduction (specific for M. pneumoniae), Complement fixation
Detection of antibody production by ELISASerology: complement fixation (CF), neutralization (N) and hemagglutination-inhibition (HAI); Detection of antibodies and the hexon antigen by ELISA.
Principles of the assayThe qualitative immunoenzymatic determination of IgM-class antibodies against Mycoplasma pneumoniae is based on the ELISA (Enzyme-linked Immunosorbent Assay) technique.
Microtiter strip wells are precoated with Mycoplasma pneumoniae antigens to bind corresponding antibodies of the specimen. After washing the wells to remove all unbound sample material horseradish peroxidase (HRP) labelled anti-human IgM conjugate is added. This conjugate binds to the captured Mycoplasma pneumoniae-specific antibodies. The immune complex formed by the bound conjugate is visualized by adding Tetramethylbenzidine (TMB) substrate which gives a blue reaction product. The intensity of this product is proportional to the amount of Mycoplasma pneumoniae-specific IgM antibodies in the specimen. Sulphuric acid is added to stop the reaction. This produces a yellow endpoint colour. Absorbance at 450 nm is read using an ELISA microwell plate reader.
Storage and StabilityThe reagents are stable up to the expiry date stated on the label when stored at 2-8C.
ReferencesClyde WA Jr:Clinical overviwe of typical M. pneumoniae infections.Clin.Infect.Dis 1993 Aug;17 Suppl 1:S32-6 MedlineE.Jacobs.1993.Serologicals Diagnosis of M. peumoniae Infections:Current Prodedures.Clinical Infectious Diseases.17(suppl 1) 79-82 Foy,H.M.1993.Infections caused by M. pneumoniae and possible populations of patients.Clinical Infectious Diseases.17 (suppl 1) 37-46 Handley J.G.,andL.D.Gray.1997.The incidence of M. pneumoniae Board Family Practice 11(6):425-429 Vikerfors, T.,Brodin, G.,Grandien, M., Hirshberg,L., Krook,A.,and C.A.Petterssonspecific IgM antibodies for the diagnosis of M. pneumoniae infections Scand.J.Infect.Dis.20(6):601-610 Wiegand, R.:M.pneumoniae.In:Brandis, H., W.Kohler,H.J.Eggers,G.Pulverer(ed.):Med. Mikrobiologie 1994.Gustav Fischer Verlag Stuttgart,Jena,New York (1994) 767-769.
Mehr Informationen
Artikelnummer AVIGWB-2EB8D1-96W
Hersteller Aviva Systems Biology
Hersteller Artikelnummer GWB-2EB8D1-96W
Green Labware Nein
Verpackungseinheit 96 Wells
Mengeneinheit PAK
Produktinformation (PDF)
×
MSDS (PDF)
×